Edgar Tracker

LNTH Lantheus Holdings, Inc.

Nasdaq · CIK 1521036 · In Vitro & In Vivo Diagnostic Substances

SEC company page

Public articles

No public articles yet. Follow LNTH to track filings and write notes.

Recent filings

–

Form Filed Title Accession
8-K2026-10-228.01 Other Events0001193125-26-428324
8-K2026-10-145.07 Submission of Matters to a Vote of Security Holders0001193125-26-421732
DEFA14A2026-10-02DEFA14A0001193125-26-412567
8-K2026-10-028.01 Other Events0001193125-26-412563
SCHEDULE 13D/A2026-09-23—0001193125-26-399446
DEFA14A2026-09-21DEFA14A0001193125-26-396661
8-K2026-09-218.01 Other Events0001193125-26-396654
DEFA14A2026-09-17DEFA14A0001193125-26-393460
DEFM14A2026-09-08DEFM14A0001193125-26-384284
SCHEDULE 13D/A2026-09-04—0001193125-26-383775
SCHEDULE 13G2026-09-04—0001193125-26-383762
SCHEDULE 13D2026-09-04—0001193125-26-383754
S-82026-09-02S-80001193125-26-379372
PREM14A2026-08-26PREM14A0001193125-26-365886
DEFA14A2026-08-13DEFA14A0001193125-26-349639
SCHEDULE 13G/A2026-08-13—0000908834-26-000401
10-Q2026-08-0610-Q0001193125-26-336795
8-K2026-08-062.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-336771
DEFA14A2026-08-04DEFA14A0001193125-26-332873
DEFA14A2026-08-04DEFA14A0001193125-26-331150